SL-701

Stemline Therapeutics Announces the Presentation of Clinical Trial Results With a Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Society of Neuro-Oncology (SNO) Annual Meeting
Yahoo/Globe Newswire
Sat, 11/23/13 - 12:37 pm
SL-701
brain cancer
Stemline Therapeutics
Stemline Therapeutics gains ground after saying it will report data on cancer therapy
Yahoo/AP
Tue, 11/19/13 - 12:32 pm
Stemline
SL-701
brain cancer